Conflict of Interest Disclosures: Dr Mehran reported receiving grants to the institution from Abbott Laboratories, Abiomed, Applied Therapeutic, AstraZeneca, Bayer, Beth Israel Deaconess, Chiesi, Concept Medical, CSL Behring, Medtronic, Novartis Pharmaceuticals, and OrbusNeich; receiving personal fees from Abbott Laboratories, Boston Scientific, Cine-Med Research Institute, Janssen Scientific Affairs, Medscape/WebMD, Sanofi, and Siemens Medical Solutions; receiving personal fees to the institution from Abbott Laboratories, Bristol-Myers Squibb, CardiaWave, Chiesi, Concept Medical, DSI, Duke University, Idorsia Pharmaceuticals, Magenta Medical, Medtronic, and Novartis; consulting for Regeneron Pharmaceuticals, serving on the data safety monitoring board for Watermark Research Partners; having equity in CardioWave, Applied Therapeutics, Claret Medical, Elixir Medical, and STEL; and being an associate editor of American College of Cardiology and JAMA Cardiology outside the submitted work. Dr Kalra reported being Chief Executive Officer and Creative Director of makeadent.org during the conduct of the study. No other disclosures were reported.